Hi, Shrewd!        Login  
Shrewd'm.com 
A merry & shrewd investing community
Best Of MacroBest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd
Search
Shrewd'm.com Merry shrewd investors
Search
Best Of MacroBest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd


The week's question
In December 2024, in the thread "Re: BRK: Why Not XOM?", BreckHutHigh asked the members: "What about the long road trips with kids?" This week it is put to everyone again. The button below opens the small thread re-asking it - read what others have said so far, then give your own answer as an ordinary reply.
Answer this questionContinue to Shrewd'mThis note won't appear again
Personal Finance / Macroeconomic Trends & Risks
Unthreaded | Threaded | Whole Thread (23) |
Author: Knighted   😊 😞
Number: of 4460 
Subject: Re: Big data: shingles vaccine lowers dementia risk
Date: 06/22/26 9:03 AM
Post New | Post Reply | Report Post | Recommend It!
No. of Recommendations: 11
As for the shingles vaccine (which was entirely free to me, as it was and is to many others), even if there is only strong, but not yet sufficient evidence for the dementia aspect, where is the harm in getting it, especially since it's a two for one: shingles elimination or relief and potentially dementia reduction.

I had an interesting debate recently with a relative.

I fully support vaccination and have little concern about long-term side effects from vaccines, but I tend to be far more cautious about newer medications intended for chronic, long-term use, including GLP-1s.

But my relative holds the opposite views and couldn't understand how I could be comfortable with one but not the other.

What finally made it click for them was when I explained that a key difference is the duration of exposure.

With vaccines, the components are present in the body for a very brief period of time. So any side effects from it should show up fairly quickly. The lasting effect comes from the immune system's response and memory, not from the vaccine continually acting on the body for years.

By contrast, someone taking a long-term medication exposes their body to that medication's effects continuously for months, years, or even decades.

Because of that difference, I prefer to see extensive long-term safety data for a medication intended for long term use, whereas I don't have those concerns over a vaccine that is administered once or only occasionally.

It's not that I assume newer long-term medications are unsafe, but the risk-benefit calculation is very different when the body is being exposed to a treatment over such a long period of time.

That's why I don't see the two positions as contradictory. To me, they reflect different levels of caution based on fundamentally different patterns of exposure.
Post New | Post Reply | Report Post | Recommend It!
Print the post
Members reply directly to Knighted here — and replies get answered. Reading is free; so is joining the conversation. Join Shrewd'm »
This community has written 4,454 posts about Macroeconomic Trends & Risks. The article-length ones it recommended most:
AI Tarpits · 36 recs · 2026
End of an era - profit slowdown · 36 recs · 2023
Control Panel: Trend changes in 2026 · 34 recs · 2026
From the Oregon Bay Area (a blogger) · 33 recs · 2025
Lerner Symmetry Theorem · 32 recs · 2025
Unthreaded | Threaded | Whole Thread (23) |


Announcements
Macroeconomic Trends & Risks FAQ
Contact Shrewd'm
Contact the developer of these message boards.

Best Of Macro | Best Of | Favourites & Replies | All Boards | Followed Shrewds | Open Questions | Moving a community